Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Recruiting

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

NCT05904106

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
  • Universitätsklinikum Aachen Aachen, Germany
  • Universitätsklinikum Augsburg Augsburg, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
View all 18 locations
View Trial Details
Recruiting

Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)

NCT04707300

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +11 more
Locations
  • Hôpital Saint Louis Paris, France
  • Service d'Hématologie et thérapie cellulaire / CHU of Bordeaux Pessac, France
  • IUCT Oncopole Toulouse Toulouse, France
  • Institut Gustave Roussy Villejuif, France
View Trial Details
Recruiting

Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)

NCT05534087

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +13 more
Locations
  • National Cancer Center Goyang, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Dong-A University Hospital Busan, South Korea
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
View all 13 locations
View Trial Details

Related conditions